Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Hair follicle regeneration possible, more research needed.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Stem cells could be a better treatment for hair loss by reactivating dormant hair follicles.

Advancements in cultured models improve understanding and treatment of gallbladder cancer.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.